December 17, 2009 (Ann Arbor, Michigan) — New laboratory research suggests that the COX-2 inhibitor celecoxib (Celebrex, Pfizer), might impede the action of "baby" aspirin [1]. Dr Gilad Rimon ...

LONDON, UK — Both CV-event rates and prevalence of serious gastrointestinal complications were surprisingly low in people without heart disease taking either celecoxib (Celebrex, Pfizer) or ...

Jeffrey Brown talks with health correspondent Susan Dentzer and Dr. John Reveille, director of the Division of Rheumatology at the University of Texas Health Science Center in Houston, about the ...

A study released today may mean that the painkiller celecoxib, once sold under the brand name Celebrex, is safer than prescription doses of ibuprofen or naproxen. That is if the study, which is ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with standard chemotherapy. An analysis of patients with stage III colon patients ...

The addition of aspirin appears to the modify the cardiovascular and overall safety of nonsteroidal anti-inflammatory drug (NSAID) therapy, specifically the beneficial safety profile of celecoxib over ...

Celecoxib (brand name Celebrex) is a type of nonsteroidal anti-inflammatory drug (NSAID), called a COX-2 inhibitor. Like traditional NSAIDS, celecoxib blocks the COX-2 enzyme in the body that ...

Celecoxib (also known by its brand name Celebrex) may help prevent non-melanoma skin cancers in patients with extensive actinic keratosis, which is often a precursor to these cancers, according to a ...

The findings, stemming from basic science research and a retrospective analysis, are particularly concerning given changes to the drug’s label clearing low-dose celecoxib against charges of an ...

Seventy-nine adults with osteoarthritis pain for at least one month were enrolled in a trial program to compare sustained-release paracetamol (acetaminophen) 1.33 g three times daily vs. celecoxib ...